USDA Webinar: USDA's Role in Advancing One Health: Zoonotic Diseases and Beyond
2025-01-29 12:00 - 13:00 (America/Chicago) | Zoom virtual event
Join the United States Department of Agriculture for an engaging webinar highlighting USDA’s One Health activities, with a focus on addressing zoonotic diseases such as Highly Pathogenic Avian Influenza (HPAI), SARS-CoV-2, and rabies, while also exploring USDA’s broader contributions to the National One Health Framework, its historical successes in eradicating tuberculosis and brucellosis from the U.S. cattle population, and the current efforts to protect public health, agriculture, and wildlife. Designed for One Health professionals and the public, this session provides an in-depth look at USDA’s collaborative, multisectoral approach to managing diseases at the intersection of human, animal, plant and environmental health.
Register today

2025 NIAMRRE Conference
2025-05-13 08:00 - 2025-05-15 12:00 | Embassy Suites research triangle Raleigh NC, 201 Harrison Oaks Boulevard, Cary, NC, 27513
CHANGING PERSPECTIVES ON AMR

NIAMRRE is excited to be holding our fifth annual conference, hosted by NC State University in Raleigh, North Carolina, May 13-15, 2025. Bringing together professionals within academia, industry, and government from across the One Health spectrum (plants, animals, humans, and the environment), we will work together in “Changing Perspectives on AMR.”
With a mix of presentations, panels, facilitated discussions, workshops, and informal gatherings, you will leave his conference with new connections and actionable steps we can take together to combat antimicrobial resistance.

➤ SUPER EARLY BIRD: Save $100 when you register now through December 31 | Click here for more details

Webinar: AMR Dashboard Data Governance Handbook
2025-07-24 12:00 - 13:00
Live Webinar | Free
Through cooperative agreements with the USDA APHIS, NIAMRRE and other NIAMRRE-member institutions have been working to improve access to information on antimicrobial resistance (AMR) in domesticated animals through the development of an AMR Dashboard Ecosystem which will leverage AMR data generated in veterinary diagnostic laboratories (VDLs) across the country.
Data governance will play a vital role in managing the AMR Dashboard Ecosystem to meet the expectations and address concerns of data providers (i.e., VDLs) and to satisfy the needs of data users. Therefore, a Data Governance Handbook has been developed to guide the management and responsible use of AMR data within the AMR Dashboard Ecosystem
On July 24, 2025 at 12 pm CT, NIAMRRE will host a webinar to present the newly developed AMR Dashboard Data Governance Handbook, and you are invited to learn more about its framework and provide feedback. Register

Why Attend?

Understand the Handbook’s Framework: Gain insights into principles, roles and responsibilities, and governance structure for collecting AMR data.
Learn Best Practices: Discover strategies for implementing effective data governance in AMR initiatives, including process, policy, and technical safeguards to protect sensitive data.
Engage with Experts: Ask questions or provide your feedback on the Handbook at the end of the presentation.

Who Should Attend?

Veterinary diagnostic laboratory representatives.
Public and animal health researchers.
Federal agency personnel involved in AMR surveillance and policy.
Any stakeholder interested in learning more about the data governance framework developed for the AMR Dashboard Ecosystem.

Don’t miss this opportunity to be at the forefront of AMR data governance!
Register now
If you have questions or if the date and time of the webinar do not work for you, but you are still interested in reviewing the Handbook and providing feedback, please contact us at amrdashboard@niamrre.org

Future of Fungi: Solutions, Trends, & Challenges
2025-09-11 13:00 - 14:00 | Zoom virtual event
Join NIAMRRE on Thursday, September 11, from 1:00 p.m. to 2:00 p.m. CT for a virtual panel discussion with leading experts in mycology and infectious disease. Hear from Dr. Tom Chiller, former Senior Advisor for strategy, DFWED for the CDC and current Chief Medical Officer and VP Strategic Innovations at IMMY, Dr. Karren Norris, Professor of Infectious Diseases at the University of Georgia, and Dr. Steven Harris, Department Chair, Plant Pathology, Entomology, and Microbiology at Iowa State University as they explore emerging trends, challenges, and solutions in fungal disease from a One Health perspective. Register now
Attend this virtual event to discover:

Critical challenges in the diagnostics and management of fungal infections
Novel solutions in technology and prevention
Emerging trends and behavior change regarding fungal disease

Don’t miss your chance to be part of this vital conversation. Register today and take a step towards understanding the fascinating world of fungi and their impact on health

Featured Speakers

Dr. Steven Harris possesses almost 40 years of experience working on the physiology, genetics, molecular biology, cell biology, and genomics of yeasts and filamentous fungi. As an independent investigator, his research program has sought to understand the mechanisms underlying hyphal morphogenesis and septum formation in the model filamentous fungus Aspergillus nidulans as well as other members of the genera Aspergillus and Penicillium. More recent efforts have focused on characterization of adaptations that enable fungi to colonize extreme environments. The latter project includes extensive field surveys focused on the isolation and identification of extremotolerant fungi. His research program has been supported by funding from NSF, NASA, and the Canadian agencies NSERC, CIHR, and CFI. Dr. Harris also has considerable experience teaching biology and mycology courses to an audience largely composed of pre-health majors. He currently serves as a Department Chair with a research appointment.

Dr. Karen Norris, is professor of Infectious Diseases and the Charles H. Wheatley Chair in Immunology & Translational Biomedical Research at the Center for Vaccines and Immunology at the University of Georgia. Her laboratory has developed and is testing a broadly protective vaccine and immunotherapeutic agents to prevent and treat fungal infections, including pulmonary aspergillosis and invasive candidiasis. She holds patents for related technologies and her work has led to the establishment of NXT Biologics, Inc, a company whose goal is the advancement of life-saving vaccines and immunotherapies for fungal diseases.

Dr. Tom Chiller led the CDC’s Mycotic Diseases Branch for over two decades, shaping the global response to life-threatening fungal infections like Candida auris and cryptococcal meningitis. From launching the FungiSurv surveillance system to securing fungal pathogens’ inclusion on WHO’s priority pathogen list, his impact has been monumental. Dr. Chiller sits on the Member Board of Trustees for the Global Action For Fungal Infections (GAFFI). Now, he joins IMMY as the Chief Medical Officer and VP Strategic Innovations to accelerate their mission of Improving Health & Saving Lives with affordable, accessible fungal diagnostics worldwide.

Harnessing Phages: Next-Gen Antimicrobial Approaches
2025-11-13 00:00 | Zoom virtual event
Join NIAMRRE on Thursday, November 13, from noon to 1:00 p.m. CT for a virtual panel discussion with leading experts in Phage technologies across One Health sectors. Hear from Dr. Tobo Loazia, CEO of HEDROS, Mathew Tebeau, COO of Phagelux Agrihealth, and Dr. Daniel Czyz, Associate Professor at the University of Florida, as they explore emerging trends, challenges, and innovative solutions in Phage technology, showcasing its promising role as a powerful alternative to traditional antibiotics. Register now
Attend this virtual event to discover:

Critical challenges to the development of phage technologies
Novel solutions and applications for phage treatments
Emerging trends and behavior change regarding the use and adoption of phage

Don’t miss your chance to be part of this invigorating conversation. Register today and expand your knowledge of this bleeding-edge technology that could redefine our approach to AMR.
